Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Andreas Evers
Scientific Director in Antibody Discovery & Protein Engineering, Global Research & Development, Discovery Technologies at Merck Healthcare
Speaker

Profile

Andreas Evers, PhD, is Scientific Director in Antibody Discovery & Protein Engineering, Global Research & Development, Discovery Technologies at Merck Healthcare KGaA. Since October 2020, he has focused on computer-aided assessment and optimization of new biological entities. He obtained his PhD in Computational Chemistry with Professor Gerhard Klebe at Philipps University of Marburg in 2000. Before joining Merck Healthcare KGaA, he worked at Sanofi from 2003, initially in computer-aided drug design for small-molecule projects and later on therapeutic peptides and proteins. His research activities include the implementation and application of in silico and AI approaches to design molecules with desired target activity and developability properties.

Agenda Sessions

  • A Combined Computational and Experimental Cascade for Variable Domain Assessment and Optimization Towards Developable Multispecific Antibodies

    1:45pm